NetworkNewsBreaks Archive - Page 217 of 2154

MondayApr 28, 2025 1:25 pm

NetworkNewsBreaks – AirJoule Technologies Corporation (NASDAQ: AIRJ) Secures $15 Million Private Placement Led by GE Vernova

AirJoule Technologies (NASDAQ: AIRJ) announced it has entered into subscription agreements for a $15 million private placement anchored by GE Vernova and other investors to accelerate commercialization of its AirJoule® system, which extracts pure water from air using low-grade waste heat. The net proceeds will fund pilot deployments of the AirJoule® A1000™ units in 2025. AirJoule and GE Vernova also launched a strategic project to integrate the technology into GE Vernova’s product offerings for industrial water production. To view the full article, visit https://nnw.fm/MxHLc About AirJoule Technologies Corporation AirJoule Technologies Corporation (NASDAQ: AIRJ) (formerly Montana Technologies Corporation) is the developer…

MondayApr 28, 2025 12:29 pm

NetworkNewsBreaks – Brazil Potash Corp. (NYSE-American: GRO) Appoints Marcelo Lessa to Advisory Board

Brazil Potash (NYSE-American: GRO) announced the appointment of Marcelo Lessa to its advisory board. Lessa, who brings over 30 years of agriculture finance and investment expertise including 16 years at the IFC/World Bank, will support Brazil Potash’s construction financing strategy for its Autazes Project. His extensive experience in securing funding for major agricultural and infrastructure projects is expected to play a key role as the company advances development of its critical mineral potash asset. To view the full article, visit https://nnw.fm/WJyeQ About Brazil Potash Brazil Potash (NYSE-American: GRO) (www.brazilpotash.com) is developing the Autazes Project to supply sustainable fertilizers to one…

MondayApr 28, 2025 10:15 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) Prices $13.8 Million Public Offering

BriaCell Therapeutics (Nasdaq: BCTX, BCTXZ) (TSX: BCT) announced the pricing of an underwritten public offering of 3,066,666 units at $4.50 per unit for gross proceeds of approximately $13.8 million. Each unit includes one common share or pre-funded warrant and one warrant exercisable at $5.25 per share. The offering, led by ThinkEquity, is expected to close on April 28, 2025, subject to customary conditions. BriaCell plans to use the net proceeds for working capital, corporate purposes and advancing business objectives. To view the full article, visit https://nnw.fm/bi0fN About BriaCell Therapeutics BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to…

MondayApr 28, 2025 9:48 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Showcases ADIO® Technology at NFL Alumni Health Draft Week Event

Datavault AI (NASDAQ: DVLT) highlighted its ADIO® tone technology at NFL Alumni Health’s 16th Annual Draft Week event on April 24, 2025, delivering interactive tones synced with top draft picks and geo-targeted health messages across the venue. The platform enabled real-time fan engagement without screens or manual input and supported cardiovascular health awareness for former athletes. Datavault AI’s deployment demonstrated how AI-powered tone technology can deepen audience interaction and create new monetization opportunities at major live events. To view the full press release, visit https://nnw.fm/w3D52 About Datavault AI Inc. Datavault AI (Nasdaq: DVLT) is leading the way in AI experience, valuation,…

MondayApr 28, 2025 9:31 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances RTNova Platform with IL15 Superagonist Payload

Calidi Biotherapeutics (NYSE American: CLDI) announced the selection of IL15 superagonist (IL15-IL15Ra) as the first therapeutic payload for its systemic antitumor virotherapy platform, RTNova. Preclinical data presented at the AACR Annual Meeting show that Calidi's engineered vaccinia virus can deliver IL15 superagonist directly into the tumor microenvironment, significantly boosting immune response and tumor elimination while minimizing systemic toxicity. The RTNova platform aims to treat metastatic cancers by enabling systemic delivery of tumor-targeted virotherapies. To view the full press release, visit: https://nnw.fm/m7Yjj About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s…

FridayApr 25, 2025 3:59 pm

NetworkNewsBreaks – Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, was featured in a recent article that discussed its innovative AVERSA(TM) abuse-deterrent technology and business model. “AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao,” the article reads. “The company’s…

FridayApr 25, 2025 1:53 pm

NetworkNewsBreaks – Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project Poised to Fuel Modern Tech with Critical PGMs

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is strategically positioning itself to become a key player in the expanding platinum group metals (“PGMs”) sector, driven by the essential role of PGMs in next-gen technology and industrial applications. PGMs serve critical functions in catalytic converters, fuel cells, catalysts in various industrial processes, electronics and the medical sector. These metals are also expected to play an even more crucial role in advancing sustainable technologies amid global efforts to reduce carbon emissions. The company’s Waterberg Project, located in South Africa’s renowned Bushveld Complex, is a large-scale, low-cost, bulk-mineable deposit with a particular focus…

FridayApr 25, 2025 1:40 pm

NetworkNewsBreaks – Newton Golf Company (NASDAQ: NWTG) Gains Momentum on Champions Tour with Golf.com Spotlight

Newton Golf Company Inc. (NASDAQ: NWTG), a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design, has seen its Newton Motion shafts rapidly gain popularity on the Champions Tour, recently earning a feature on Golf.com for their innovative performance benefits tailored to senior players. The shafts utilize a unique variable stiffness profile—more flexible in the midsection and stiffer at the tip and butt ends—resulting in improved energy transfer, higher launch angles, and increased distance. These design advantages have made them a go-to choice for many veteran professionals seeking more consistency and power in their drives. To read…

FridayApr 25, 2025 10:30 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Report First Quarter Fiscal Year 2025 Financial Results on May 8

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software, and services, will release its first-quarter fiscal 2025 results before market open on Thursday, May 8, 2025. D-Wave will host a conference call featuring CEO Dr. Alan Baratz and CFO John Markovich at 8:00 a.m. ET that day to discuss financial results and business outlook. The earnings press release and webcast replay will be available on the D-Wave Investor Relations website. To view the full press release, visit https://nnw.fm/GMcLc. About D-Wave Quantum Inc. D-Wave is a leader in the development and delivery of quantum computing…

FridayApr 25, 2025 9:51 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Grants Inducement Stock Option to New CEO Eric Poma

Calidi Biotherapeutics (NYSE American: CLDI) a clinical-stage biotechnology company advancing targeted antitumor virotherapies, announced the approval of an inducement non-qualified stock option grant to new Chief Executive Officer Eric Poma, Ph.D. The grant includes the option to purchase 726,412 shares at an exercise price of $0.469, the closing price of Calidi’s common stock on April 22, 2025. The options will vest over four years, with 25% vesting on April 22, 2026, and the remainder vesting in equal monthly installments through April 22, 2029, in accordance with Section 711 of the NYSE American LLC Company Guide. To view the full press…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks